Could Paying for Obesity Medications Offset Obesity Care Costs?
With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will decrease obesity costs.
Related Articles
Belgium to become first EU country to ban disposable vape sales
Belgium will in January become the first European Union country to ban sales of disposable vapes because of concerns about their use among children and…
FDA confirms tirzepatide shortage is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to…
Vertex’s painkiller results match placebo in study, shares tumble
Vertex Pharmaceuticals said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed little difference versus a placebo in…
Buccal fat removal: What to know about cheek reduction surgery and nonsurgical ways to lose facial fat – Harvard Health
Learn about buccal fat removal surgery and explore non-surgical alternatives for reducing facial fat….
DJI evades US ban but has one year to prove its products aren’t a national security threat
The NDAA (National Defense Authorization Act) spending bill has just been release and it grants DJI a year’s grace before it’s potentially banned in the…
MCP 60 Seconds With Stanislav Henkin, MD, on Post-Pulmonary Embolism Syndrome
View Full-Length Video at: https://youtu.be/ggAcRxKZeywRelated Article Available at: https://mayocl.in/3BN0IMP
FDA confirms tirzepatide shortage is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to…
US FDA says Lilly’s weight-loss drug shortage resolved
The U.S. Food and Drug Administration said on Thursday that Eli Lilly’s weight-loss drug shortage has been resolved, following a re-evaluation of the drug’s supply…
Antibiotic Use Not Linked to Incident Dementia, Cognitive Impairment
WEDNESDAY, Dec. 18, 2024 (HealthDay News) — Any or repeated use of antibiotics is not associated with incident dementia, cognitive impairment/no dementia (CIND
GLP-1 users receiving new diagnoses faster than before
Discover the latest trend in GLP-1 medication usage: An increase in first-time diagnoses after just 15 days. Findings from Truveta Research and Reuters.
